Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Falls 2.22% Today

Published:   29 September 2026 at 10:23:29 AM IST

Glaxosmithkline Pharmaceuticals Share Price fell to Rs 2,833.65 on 29 September 2026, down 2.22% from the previous close, with the company valued at Rs 47,719.14 crore in market capitalisation. The move places GLAXO back in focus for Glaxosmithkline Pharmaceuticals Share Price Today searches, especially because the day’s data confirms a clear decline but does not establish any company-specific catalyst. In GLAXO Stock News today, the verified figures show a gap between the opening price and the day’s closing level, while the market-cap category remains Large Cap. For readers tracking Glaxosmithkline Pharmaceuticals Share Price News, the relevant question is not only what changed in price, but also how the current valuation, sector benchmark and peer set compare with this level.

Univest is covering the stock as part of its live market coverage, and the data available here supports a factual Glaxosmithkline Pharmaceuticals Share Price update rather than a reasoned event narrative. The stock’s movement is best read through today’s price action, its fundamentals and the broader healthcare context.

Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,833.65
Previous Close	Rs 2,897.85
Today's Move	-Rs 64.20 (-2.22%)
Open	Rs 2,880.05
High	Rs 2,893.7
Low	Rs 2,833.65
Turnover	Rs 0.3 crore
Market Capitalisation	Rs 47,719.14 crore
Market Cap Category	Large Cap

Glaxosmithkline Pharmaceuticals Share Price Today opened at Rs 2,880.05, moved between a day high of Rs 2,893.70 and a day low of Rs 2,833.65, and ended at Rs 2,833.65. That is a day change of Rs -64.20, or -2.22%, versus the previous close of Rs 2,897.85. The stock’s turnover stood at Rs 0.3 crore. The price action shows that the day’s low matched the closing price, which is useful context for readers following GLAXO Share Price Live and Glaxosmithkline Pharmaceuticals Share Price Update pages.

With a market capitalisation of Rs 47,719.14 crore, the company sits in the Large Cap category. For Glaxosmithkline Pharmaceuticals Share Price watchers, the key factual takeaway is that today’s trade ended below both the open and the previous close, while the published numbers confirm the decline without identifying a company-specific reason. In GLAXO Share Price News, this is a clean same-day fall that should be read alongside the company’s valuation and healthcare industry context. That sets up the next question: what do the financial metrics and sector comparisons say about the stock’s current standing?

Glaxosmithkline Pharmaceuticals (GLAXO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 47,719.14 crore
P/E Ratio	45.96x
P/B Ratio	19.48x
ROE	48.76%
ROCE	66.79%
EPS	Rs 63.05
Book Value Per Share	Rs 148.77
Dividend Yield	1.97%

Glaxosmithkline Pharmaceuticals Share Price today must be read with its valuation profile. The stock trades at a price-to-earnings ratio of 45.96 and a price-to-book ratio of 19.48, both well above many large listed names and also above the industry medians shown later in this article. For investors following GLAXO Share Price News or Glaxosmithkline Pharmaceuticals Fundamental Analysis, those multiples indicate that the market is assigning a substantial premium to each unit of earnings and book value.

The company’s return on equity is 48.76% and return on capital employed is 66.79%, which are strong absolute profitability measures. Earnings per share stands at Rs 63.05, book value per share is Rs 148.77, and dividend yield is 1.97%. Those figures matter because EPS reflects earnings attributable to each share, book value per share shows accounting net worth behind each share, and dividend yield reflects historical payout relative to the current Glaxosmithkline Pharmaceuticals Share Price. With no fresh catalyst in the supplied data, the fundamentals provide the main context for understanding why the stock remains closely watched in GLAXO Stock News and Glaxosmithkline Pharmaceuticals Stock Analysis.

From a company-level perspective, the market-cap figure of Rs 47,719.14 crore places the business among the larger names in the healthcare universe, and the valuation metrics suggest that investors are already attaching a significant premium to the stock relative to earnings and net asset value. That naturally leads to ownership, sector and peer context, which offer a fuller picture for anyone tracking Glaxosmithkline Pharmaceuticals Share Price Today.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	45.96x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	19.48x
Benchmark Median P/B	2.88x
Benchmark Average P/B	4.34x
Company ROE	48.76%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.68%
Company ROCE	66.79%
Benchmark Median ROCE	13.61%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 47,719.14 crore
Benchmark Median Market Cap	Rs 783.26 crore
Benchmark Average Market Cap	Rs 14,389.26 crore

Glaxosmithkline Pharmaceuticals operates in Healthcare, within Pharmaceuticals & Drugs, and the benchmark scope supplied here is the same industry across 199 companies. In that set, the company’s P/E of 45.96 sits above the sector median of 32.59 but below the sector average of 49. Its P/B of 19.48 is also well above the sector median of 2.88 and the sector average of 4.34. That comparison matters for Glaxosmithkline Pharmaceuticals Share Price because it shows the stock is valued at a richer level than the typical industry name on both earnings and book-value measures.

The same industry benchmark also shows company ROE of 48.76% versus a median of 11.7% and average of 10.68%, while ROCE of 66.79% is above the median of 13.61% and average of 13.4%. In market-cap terms, the industry median is Rs 783.26 crore and the average is Rs 14,389.26 crore, whereas GLAXO’s market capitalisation is Rs 47,719.14 crore. That places the company well above the industry midpoint on size. For readers searching Glaxosmithkline Pharmaceuticals Share Price Fall or Glaxosmithkline Pharmaceuticals Stock News Today, the important point is that today’s decline occurred against a background of premium valuation and strong reported returns, not against weak operating-return figures in the supplied dataset.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla	CIPLA	1,12,875.68	33.29	3.19	11.83	16

Among the supplied peers, Glaxosmithkline Pharmaceuticals Share Price sits in a compact but high-valued part of the healthcare universe. Its P/E of 45.96 is higher than Sun Pharmaceutical Industries at 36.5, Cipla at 33.29, Dr. Reddy’s Laboratories at 31.67 and Zydus Lifesciences at 26.79, but lower than Divi’s Laboratories at 86.51, Torrent Pharmaceuticals at 84.92, Laurus Labs at 99.43 and slightly below Mankind Pharma at 49.33.

On return ratios, GLAXO’s ROE of 48.76% and ROCE of 66.79% are above the values shown for every peer in the supplied list, including Lupin at 27.11% ROE and 28.86% ROCE. Its market capitalisation of Rs 47,719.14 crore is below Sun Pharma and the larger peers such as Divi’s and Torrent, but above several other listed names in the set. For Glaxosmithkline Pharmaceuticals Share Price Today analysis, that means the stock combines a sizable market value with unusually strong return metrics relative to the peer sample, even though today’s price action was negative.

Why Investors Are Watching Glaxosmithkline Pharmaceuticals

• Glaxosmithkline Pharmaceuticals Share Price fell 2.22% today to Rs 2,833.65.
• The stock closed below the previous close of Rs 2,897.85 after opening at Rs 2,880.05.
• Day high was Rs 2,893.70 and day low was Rs 2,833.65.
• Market capitalisation stands at Rs 47,719.14 crore, and the company is in the Large Cap category.
• P/E of 45.96, P/B of 19.48, ROE of 48.76% and ROCE of 66.79% frame the current GLAXO Share Price story.

About Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company sits within a large listed healthcare peer group and is tracked by investors who follow GLAXO Share Price Today, Glaxosmithkline Pharmaceuticals Stock News and Glaxosmithkline Pharmaceuticals Share Price News. Its supplied market context centres on valuation, returns and industry comparison rather than a company narrative built around unstated business details.

For readers scanning Glaxosmithkline Pharmaceuticals Share Price and GLAXO News Today, the relevant company facts are its market capitalisation, valuation multiples, profitability ratios, earnings per share, book value and dividend yield. Those metrics are enough to place the stock within the healthcare sector without adding assumptions beyond the supplied data.

Track Glaxosmithkline Pharmaceuticals Share Price on Univest

Use Glaxosmithkline Pharmaceuticals (GLAXO) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Track Glaxosmithkline Pharmaceuticals Share Price on Univest for live updates, market cap, valuation ratios, shareholding pattern, 52-week levels and company market insights. Univest also brings together GLAXO Share Price Live, fundamental ratios and sector comparison in one place for faster stock news tracking.

Frequently Asked Questions

Why did Glaxosmithkline Pharmaceuticals Share Price fall today?

Ans.  The supplied data confirms that Glaxosmithkline Pharmaceuticals Share Price fell 2.22% to Rs 2,833.65, but it does not establish a company-specific catalyst. The move is best read through today’s price action and valuation context.

What is Glaxosmithkline Pharmaceuticals Share Price today?

Ans.  Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,833.65. The stock declined from the previous close of Rs 2,897.85, and the day’s range ran from Rs 2,833.65 to Rs 2,893.70.

How much did GLAXO fall in today’s trade?

Ans.  GLAXO fell Rs -64.20, which equals -2.22% versus the previous close. The opening price was Rs 2,880.05, so the stock stayed below both the open and the prior close by the end of the session.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals?

Ans.  The company’s market capitalisation is Rs 47,719.14 crore. That places it in the Large Cap category and well above the industry median market capitalisation of Rs 783.26 crore within the same industry benchmark.

How do GLAXO valuation metrics compare with the healthcare sector?

Ans.  GLAXO trades at 45.96 times earnings and 19.48 times book value. Those are above the industry median P/E of 32.59 and P/B of 2.88, while its ROE and ROCE are also above the benchmark median.